What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: how can we help our patients avoid those risks?
患有IBD及接受免疫调节剂和/或生物制剂治疗相关的恶性肿瘤风险:如何帮助患者避免上述风险?
C. Understanding the surgical challenges of complicated fistulae in Crohn's disease: Case studies
病例研究:了解克罗恩病复杂性瘘外科手术的挑战
D-1. How to manage the IBD patient who presents for a third opinion and has run out of options: Case studies
病例研究1:如何管理多次就诊且缺乏治疗策略的IBD患者
D-2. How to manage the IBD patient who presents for a third opinion and has run out of options: Case studies
病例研究2:如何管理多次就诊且缺乏治疗策略的IBD患者
When and how do we do resections and/or stricturoplasties for severe small bowel Crohn’s disease?
何时、如何对重度小肠克罗恩病实施切除和/或狭窄成形术?
Operating on a patient with fulminant colitis: What issues influences the final decisions?
对暴发性结肠炎患者实施手术:哪些问题会影响最终决策?
What is the best practice for using endoscopic scoring systems (Mayo, UCEIS, CDEIS, and SESCD) in our daily clinical practice (videos)?
日常临床实践中如何最佳使用内窥镜评分系统(Mayo、UCEIS、CDEIS和SESCD) (视频)?
When can we use radiologic procedures in conjunction with endoscopy for challenging, complicated IBD patients (videos)?
对于难治性复杂IBD患者,何时联用放射学检查和内窥镜(视频)?
Therapeutic techniques for dysplastic and mass lesions in the colon: targeted biopsies, EMR, and ESD (videos)
结肠发育不良和肿块病灶的治疗技术:靶向活检、内镜下粘膜切除术和内镜粘膜下层剥离术(视频)
B-1. Recognizing and managing side effects and complications due to medications used to treat IBD: Case studies
病例研究1:识别和管理IBD治疗药物的不良反应和相关并发症
B-2. Recognizing and managing side effects and complications due to medications used to treat IBD: Case studies
病例研究2:识别和管理IBD治疗药物的不良反应和相关并发症
C-1. Challenging IBD patients with concurrent viral hepatitis or an autoimmune liver disease: Case studies
病例研究1:合并病毒性肝炎或自身免疫性肝脏疾病的难治性IBD患者
C-2. Challenging IBD patients with concurrent viral hepatitis or an autoimmune liver disease: Case studies
病例研究2:合并病毒性肝炎或自身免疫性肝脏疾病的难治性IBD患者
D-1. Strategies for the prevention and treatment of opportunistic infections in IBD patients: Case studies
病例研究:IBD患者机会性感染的防治策略